Have any questions? 706-721-6582 or cts@augusta.edu
The purpose of this study is to determine whether TAK-831 improves negative symptoms of schizophrenia, when taken together with an anti-psychotic medication. Negative symptoms include reduced expression of emotions, reduced feelings of pleasure in everyday life, difficulty beginning and sustaining activities, reduced socializing, and reduced speaking.